Antibiotic Accelerator From BARDA Nears Investment Stage
This article was originally published in The Pink Sheet Daily
Federal funding could pay to help early antibiotic discovery efforts with 'fragile' pipeline still struggling.
You may also be interested in...
FDA asks groups how it can help ensure prescribing is limited for products approved under proposed new pathway, but several say, other than labeling, it may be out of the agency’s hands.
The agency is considering how to move forward as Pfizer studies a third shot after missing an efficacy endpoint in children age 2 to 5.
Commissioner nominee strikes an optimistic note as former FDA heads raise concerns about the decrease in agency credibility during the pandemic.